Comparing Plurogel to standard dressings for burn injuries
Official title: A Between Patient, Pilot Randomized Controlled Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries
Run by University of Manitoba · NCT05000983 · Data updated 2026-11-12
This study is testing whether Plurogel works better than regular dressings for treating partial thickness burns by helping patients heal faster and reducing the need for surgery.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | University of Manitoba Academic / other |
| Locations | 1 site (Winnipeg, Manitoba) |
| Status | Recruiting |
| Started | October 20, 2021 |
| Main results expected | November 30, 2028 |
| Study ends | December 31, 2029 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT05000983 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with partial thickness burns on the face or unilateral limbs requiring hospitalization.
✕Probably not a fit
Patients with total burn surface area greater than 30% or full thickness burns will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of Plurogel compared to standard antibiotic topical dressings in patients with partial thickness burns. The study aims to determine if Plurogel can reduce the need for surgical debridement and improve healing outcomes. Participants will be monitored for their recovery process, including pain management and healing time. The trial is designed to gather data on the safety and efficacy of Plurogel in treating burn injuries.
Why it matters
Potential benefit: If successful, this study could lead to improved healing and reduced surgical interventions for patients with burn injuries.
How similar studies have gone: Other studies have explored similar adjuncts for burn treatment, but definitive improvements have not been established in randomized controlled trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Persons with partial thickness face burns or unilateral limb burn injuries requiring admission. Exclusion Criteria: * Total burn surface area (TBSA) \>30%. * Burn depth full thickness or deeper on initial assessment. * Prior excision at another healthcare centre. * Patients with pre-existing malnutrition * Electrical, chemical or other unusual burn etiologies
Where it's running
-
University of Manitoba
Winnipeg, Manitoba, Canada Recruiting
Study contacts
- Study coordinator: Justin Gawaziuk, MSc
- Email: jgawaziuk@hsc.mb.ca
- Phone: 2047878682
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early detection of sepsis-related blood clotting problems in severe burn patients
This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.
-
THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers
This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.
-
Efferon LPS hemoadsorption for severe burns
This study tests whether adding Efferon LPS hemoadsorption to standard care can help burn patients with high illness scores see if their symptoms improve and prevent organ failure.
-
Wearable hip-robot training to improve walking after major lower-leg burns
This 12-week program will try using a wearable hip-assist robot during daily physiotherapy to help adults who still have walking problems six months after large lower-extremity burns walk better.
-
Tilapia skin versus regular dressings for second- and third-degree burns
This trial will test whether tilapia fish skin dressings help people with second- or third-degree burns heal better than regular dressings.
-
Presepsin blood test for early sepsis detection in severe burn patients
This project will test whether a blood marker called presepsin can detect sepsis early in adults who have severe burns covering at least 20% of their body.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.